Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
02 December 2014 10:22
Scientists have high hopes for the experimental breast cancer vaccine
An experimental vaccine described as being "very encouraging" for future treatment could be the answer to slowing the progression of breast cancer.
The jab targets a protein found almost exclusively in breast tissue and in 80% of breast cancers - called mammaglobin-A.
How the study worked
A study of 14 women with advanced breast cancer, led by Professor William Gillanders from Washington University School of Medicine, found half of those who received the vaccine showed no sign of tumour growth one year after treatment.
The jab also had a positive biological effect in those with immune systems weakened by the disease and extended periods of chemotherapy treatment, prompting modestly longer progression-free survival.
People who have survived breast cancer can arrange breast cancer travel insurance when taking holidays or travelling to visit relatives.
Prof Gillanders describes the findings as "very encouraging" for the future of breast cancer treatment.
He hopes the vaccine means a larger number of patients can be treated with potentially fewer side effects.
In light of the positive research, plans are now in the pipeline for the scientists to follow up the small pilot trial with a larger study of newly diagnosed patients who should have stronger immune systems.
Prof Gillanders adds that the ability to target mammaglobin-A is particularly exciting because it is expressed broadly in up to four-fifths of breast cancers, as tumours produce it at abnormally high levels.
What Breakthrough Breast Cancer says
The results were described as "interesting" by the breast cancer charity.
Sally Greenbrook of Breakthrough said the research could lead to a vaccine to be used as part of prevention treatment. But she highlighted the small scale of the current trial, and underlined the importance of maintaining a healthy lifestyle.
19 October 2018
Pregnant women who suffer from pre-eclampsia have a greater risk of developing dementia, new research suggests.
[more...]
18 October 2018
The UK's average life expectancy is predicted to increase from 80.8 years to 83.3 years over the next 20 years, according to new research.
17 October 2018
Family doctors are being urged to prescribe physical activity for patients living with some of the most common medical conditions.
16 October 2018
Patients with brain tumours lose out on almost £15,000 per year, a new report has revealed.
13 October 2018
Chris Grayling has given his "categorial assurance" to Parliament that a no-deal Brexit will not ground flights in and out of the UK, despite recent warnings from experts that this remains a possibility.
12 October 2018
The rising cost of fuel could force more airlines out of business, the boss of easyJet has warned.
11 October 2018
The image of the boozy backpacker might be a thing of the past as a new study suggests more and more youngsters are shunning alcohol completely.
10 October 2018
The NHS says just one in 10 drinks sold in English hospitals will be sugar-sweetened, as part of its bid to curb rising obesity levels.
09 October 2018
More than 260,000 diabetes patients were put at risk of lasting harm or even death during hospital stays last year due to medication errors, a new report has revealed.
06 October 2018
NHS patients with a specific type of lymphoma will soon be able to access a "game-changing" new treatment, health officials have revealed.
05 October 2018
People living with diabetes are being warned they might be "unwittingly" storing their insulin incorrectly.
04 October 2018
The world's first commercial jet part-powered by a new form of biofuel touches down in London on Wednesday (3rd October).